NCT01402583View on ClinicalTrials.gov

Menopause is a Critical Factor in Determining Failure of Antiviral Therapy in Women With Chronic Hepatitis C

CompletedOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

September 30, 2011

Conditions

Chronic Hepatitis C

Interventions

DRUG

PEG IFN/Ribavirin

Trial Locations (1)

41124

Gastroenterology Unit, Modena

All Listed Sponsors

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Prof. Facchinetti Fabio

OTHER

NCT01402583 - Menopause is a Critical Factor in Determining Failure of Antiviral Therapy in Women With Chronic Hepatitis C | Biotech Hunter | Biotech Hunter